Tarsons Products Ltd

Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tarsons Products Ltd

₹ 388 2.04%
22 Nov - close price
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 2,062 Cr.
  • Current Price ₹ 388
  • High / Low ₹ 574 / 378
  • Stock P/E 48.3
  • Book Value ₹ 115
  • Dividend Yield 0.52 %
  • ROCE %
  • ROE %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Mar 2024 Jun 2024 Sep 2024
60 68 69 76 71 85 106 85 99
30 33 32 38 38 41 75 66 74
Operating Profit 31 35 37 38 33 44 30 19 25
OPM % 51% 52% 53% 51% 47% 52% 29% 22% 26%
2 1 2 1 2 3 3 3 8
Interest 1 1 1 2 1 0 4 4 5
Depreciation 3 3 5 5 5 7 12 11 14
Profit before tax 28 32 33 34 29 39 17 6 15
Tax % 26% 25% 26% 26% 26% 25% 40% 36% 31%
21 24 25 25 21 29 10 4 10
EPS in Rs 1,095.21 1,225.81 4.88 4.89 4.04 5.54 1.94 0.76 1.93
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024
229 301 296
125 148 196
Operating Profit 103 153 100
OPM % 45% 51% 34%
5 8 11
Interest 3 4 10
Depreciation 14 22 40
Profit before tax 92 135 61
Tax % 25% 25% 30%
69 101 43
EPS in Rs 3,583.25 18.92 8.01
Dividend Payout % 0% 0% 25%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 9%
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -15%
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -20%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024 Sep 2024
Equity Capital 0.19 11 11 11
Reserves 244 479 602 603
34 22 269 317
18 33 90 123
Total Liabilities 296 544 972 1,054
120 189 336 480
CWIP 22 32 267 217
Investments 0 0 0 0
153 323 369 357
Total Assets 296 544 972 1,054

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024
68 83 103
-64 -138 -285
-27 130 136
Net Cash Flow -23 75 -47

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2024
Debtor Days 75 79 96
Inventory Days 277 478 572
Days Payable 35 75 65
Cash Conversion Cycle 317 482 602
Working Capital Days 108 150 193
ROCE % 35%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
47.30% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31%
9.33% 9.12% 9.33% 9.90% 9.60% 9.16% 8.64% 7.85% 6.83% 8.16% 7.95% 8.04%
6.33% 7.76% 8.06% 8.13% 8.52% 8.45% 7.38% 3.15% 2.60% 0.17% 0.11% 0.21%
37.04% 35.82% 35.31% 34.67% 34.59% 35.09% 36.67% 41.68% 43.27% 44.36% 44.63% 44.45%
No. of Shareholders 1,59,8911,25,7141,12,2271,07,0111,07,9451,05,3041,07,4401,08,2361,07,5641,02,8661,05,33099,586

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls